MedTrace Logo

New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System

NCT01860092 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2021-12-23

No results posted yet for this study

Summary

This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to include all eligible and willing subjects implanted with Argus II System in the United States.

Conditions

Sponsors & Collaborators

  • Second Sight Medical Products

    lead INDUSTRY

Principal Investigators

  • Jessy Dorn, PhD · Second Sight Medical Products, Inc.

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01860092 on ClinicalTrials.gov